Cargando…

Can BAP1 expression loss in mesothelial cells be an indicator of malignancy?

BACKGROUND: Malignant mesothelioma is a highly aggressive tumor that can be confused with a benign mesothelial lesion, especially cytomorphologic lesions. BRCA1-associated protein 1 (BAP1) acts as a tumor suppressor. In this study, we aim to investigate the value of BAP1 staining of malignant mesoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozdemir, Hanife Gulnihal, Kokten, Sermin Coban, Barisik, Nagehan Ozdemir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674764/ https://www.ncbi.nlm.nih.gov/pubmed/33153245 http://dx.doi.org/10.4132/jptm.2020.09.14

Ejemplares similares

Primary Dural Spinal Lymphoma Presentation of a Rare Spinal Tumor Case
por: Çeçen, Dilber Ayçiçek, et al.
Publicado: (2015)

Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia
por: Kushitani, Kei, et al.
Publicado: (2018)

The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas
por: Gul, Aylin Ege, et al.
Publicado: (2010)

Incidental gallbladder cancer: a retrospective clinical study of 40 cases
por: Altiok, Merih, et al.
Publicado: (2022)

Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer
por: Hirosawa, Takashi, et al.
Publicado: (2018)

Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma
por: Andrici, Juliana, et al.
Publicado: (2016)

PTK-7 Expression in Gastric Cancer: A Prognostic Determinant
por: Özçelik, Melike, et al.
Publicado: (2020)

Succinate Dehydrogenase Complex Iron Sulfur Subunit B (SDHB) Immunohistochemistry in Pheochromocytoma, Head and Neck Paraganglioma, Thoraco-Abdomino-Pelvic Paragangliomas: Is It a Good Idea to Use in Routine Work?
por: Gul, Aylin Ege, et al.
Publicado: (2021)

Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study
por: Hakim, Sarah Adel, et al.
Publicado: (2021)

Evaluation of patients admitted with musculoskeletal tuberculosis: sixteen years’ experience from a single center in Turkey
por: Ozdemir, Mikail, et al.
Publicado: (2021)

Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma
por: Tayao, Michael, et al.
Publicado: (2016)

A case of slowly progressive malignant pericardial mesothelioma suggesting the involvement of BAP1 loss
por: Fukasawa, Naoto, et al.
Publicado: (2022)

Germline BAP1 mutations predispose to malignant mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2011)

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
por: Pulford, Emily, et al.
Publicado: (2017)

Role of malignant ascites on human mesothelial cells and their gene expression profiles
por: Matte, Isabelle, et al.
Publicado: (2014)

BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma
por: Ishii, Yuki, et al.
Publicado: (2021)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
por: Song, Hao, et al.
Publicado: (2017)

Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells
por: Kolluri, Krishna Kalyan, et al.
Publicado: (2018)

Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
por: Takehara, Yusuke, et al.
Publicado: (2018)

Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells
por: Takehara, Yusuke, et al.
Publicado: (2018)

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
por: Guazzelli, Alice, et al.
Publicado: (2019)

Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
por: Figueiredo, Carlos R, et al.
Publicado: (2020)

Loss of BAP1 function leads to EZH2-dependent transformation
por: LaFave, Lindsay M., et al.
Publicado: (2015)

Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
por: Ladanyi, Marc, et al.
Publicado: (2019)

BAP1 loss defines a new class of renal cell carcinoma
por: Peña-Llopis, Samuel, et al.
Publicado: (2012)

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
por: Matatall, Katie A, et al.
Publicado: (2013)

BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification
por: Barnett, Sarah E., et al.
Publicado: (2023)

BAP1 Tumour Predisposition Syndrome Due to Whole BAP1 Gene Deletion
por: Pandithan, Dinusha, et al.
Publicado: (2022)

BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome
por: Blatnik, Ana, et al.
Publicado: (2022)

The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE
por: Treerat, Puthayalai, et al.
Publicado: (2015)

Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies
por: Yan, Yu-Chuan, et al.
Publicado: (2022)

Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression
por: Stålhammar, Gustav, et al.
Publicado: (2021)

BAP31, a promising target for the immunotherapy of malignant melanomas
por: Yu, Shaojuan, et al.
Publicado: (2015)

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012)

BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma
por: Alakus, Hakan, et al.
Publicado: (2015)

Loss of Nuclear BAP1 Expression Is Associated with High WHO/ISUP Grade in Clear Cell Renal Cell Carcinoma
por: Wi, Young Chan, et al.
Publicado: (2018)

MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer
por: Tsuboyama, Natsumi, et al.
Publicado: (2022)

RhierBAPS: An R implementation of the population clustering algorithm hierBAPS
por: Tonkin-Hill, Gerry, et al.
Publicado: (2018)

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
por: Shrestha, Raunak, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pkv3ctrvdcq17batgqhq88g1ll